ABSTRACT. Using a monoclonal anti-human IgE receptor (FctR) antibody, the percentage of FctR(+) cells among peripheral blood lymphocytes in children with or without allergic disorders was determined. The percentage of FctR(+) cells in 63 nonallergic children was 4.3 2 1.5%, which did not vary with age and was equal to that of adults (4.2 + 1.2%). Allergic younger children (0-2 yr) showed a significantly higher percentage of FctR(+) cells (7.7 f 3.0%) than nonallergic younger children (0-2 yr) (4.0 + 1.3%, p < 0.001). Similarly, in allergic younger children, serum IgE levels (geometric mean = 58.9 IU/ml) were also significantly higher than those of nonallergic younger children (geometric mean = 2.0 IU/ml) (p < 0.01). A positive correlation between the percentages of FctR(+) cells and serum IgE levels was observed (Spearman rank = 0.88, p < 0.01)) in eight allergic younger children (0-2 yr) with serum IgE levels higher than 100 IU/ml. The increase in the percentage of FUR(+) cells in allergic younger children (0-2 yr) was not a secondary phenomenon caused by serum IgE because serum IgE levels in these children were much lower than the concentration at which IgE enhance FctR expression on lymphocytes. In conclusion, FctR(+) lymphocytes may play a regulatory role in IgE synthesis in allergic younger children (0-2 yr). (Pediatr Res 24: 254-257,1988 
ABSTRACT. Using a monoclonal anti-human IgE receptor (FctR) antibody, the percentage of FctR(+) cells among peripheral blood lymphocytes in children with or without allergic disorders was determined. The percentage of FctR(+) cells in 63 nonallergic children was 4.3 2 1.5%, which did not vary with age and was equal to that of adults (4.2 + 1.2%). Allergic younger children (0-2 yr) showed a significantly higher percentage of FctR(+) cells (7.7 f 3.0%) than nonallergic younger children (0-2 yr) (4.0 + 1.3%, p < 0.001). Similarly, in allergic younger children, serum IgE levels (geometric mean = 58.9 IU/ml) were also significantly higher than those of nonallergic younger children (geometric mean = 2.0 IU/ml) (p < 0.01). A positive correlation between the percentages of FctR(+) cells and serum IgE levels was observed (Spearman rank = 0.88, p < 0.01)) in eight allergic younger children (0-2 yr) with serum IgE levels higher than 100 IU/ml. The increase in the percentage of FUR(+) cells in allergic younger children (0-2 yr) was not a secondary phenomenon caused by serum IgE because serum IgE levels in these children were much lower than the concentration at which IgE enhance FctR expression on lymphocytes. In conclusion, FctR(+) lymphocytes may play a regulatory role in IgE synthesis in allergic younger children (0-2 yr). ( FctR(+) cells (4, 5) . Using this model, it was noted that FctR(+) T cells secrete a soluble factor with an affinity for IgE (IgEbinding factor) which enhances IgE production (I@-potentiating factor) (6) . Thus, it was demonstrated that FctR(+) T cells play an essential role in rat IgE synthesis.
In humans, FctR(+) T cells producing an IgE-potentiating factor were obtained from patients with the hyper-IgE syndrome, in whom both the percentage of FctR(+) cells and serum IgE levels are increased (7) . Although the function of FUR(+) B cells, which occupy the major part of FctR(+) lymphocytes, was not clarified in animals, it was demonstrated that, in humans, these cells also enhance IgE synthesis by the secretion of an IgEpotentiating factor (8, 9) . These results suggest that, as in rats, human IgE synthesis might be regulated by FctR(+) lymphocytes.
FceR is induced on lymphocytes by soluble T cell factors (10-12); however, IgE can also enhance the expression of FccR on lymphocytes (5, 13, 14 Despite the well-known fact that serum IgE levels rise and allergic disorders develop during childhood, there are no reports on the percentage of FctR(+) lymphocytes in children. Therefore, we examined the percentage of FccR(+) cells in children, based on the assumption that, if FceR(+) cells enhance IgE production, an increase in the percentage of FccR(+) cells should be observed in younger allergic children whose serum IgE levels are still lower than those of older allergic individuals.
MATERIALS AND METHODS

Donors.
Allergic disorders were diagnosed when at least one of the following was found in children with typical symptoms: 1 ) the presence of other allergic patients in their family; 2) positive results in RAST or skin tests; 3) serum IgE levels higher than the mean + 1 SD of those of nonallergic children in this study.
Actually, levels were set at 10 IU/ml in infants, 100 IU/ml in 1-to 2-yr-old children, and 400 IU/ml in older children (3-1 5 yr).
The allergic group consisted of 76 children (46 males and 30 females); 5 1 had bronchial asthma with or without other allergic disorders and 25 had atopic dermatitis only. Of these children 90.8% (69/76), 82.9% (63/76), and 75.0% (57176) met the diagnostic criterion for l ) , 2), and 3), respectively. A total of 92.1 % (70176) of the children filled the criterion for 2) and/or 3). Patients medicated continuously with systemic corticosteroids were excluded because of their effect of reducing FceR on lymphocyte (2, 10, 15) .
The nonallergic group consisted of 63 children (34 males and 29 females) who had no allergic, immunological, or hematological problems. Blood was obtained during routine blood examinations using a three-way connector, after informed consent had been obtained from their parents and, if the children were old enough, from the patients themselves. Blood of normal and allergic adults was drawn from volunteers in our laboratory. These samples were collected between November 1986 and June 1987.
Measurement of serum IgE levels. Serum IgE levels in 74 allergic and 37 nonallergic children were determined using Pharmacia IgE RIA kits, generously provided by Shionogi and Company Ltd., Osaka, Japan. These kits are unaffected by serum agents that normally interfere with the detection of IgE. The measurable range is from 10-2000 IU/ml using the standard procedure and from 1-40 IU/ml using the high sensitivity procedure.
Preparation of lymphocytes. Peripheral blood MNC were collected by the previously described method (16) , except that heparinized blood was incubated with silica particles (KAC 2, Japan Immunoresearch Laboratories, Takasaki, Japan) at 37" C for 60 min before being layered over Ficoll-Paque (Pharmacia Fine Chemicals AB, Uppsala, Sweden) to remove phagocytes. The percentage of monocytes in MNC was less than 5%.
Cells and antibodies. The mouse IgG2b monoclonal antihuman FccR (CD23) antibody (H107) (17) and the FceR(+) human B cell line (RPMI 8866) were kindly provided by Dr. J. Yodoi (Institute for Immunology, Kyoto University, Japan). Purified mouse myeloma IgG2b protein which did not react to the antigens on human lymphocytes was purchased from Miles Scientific Div., Naperville IL. The FITC-conjugated goat antimouse IgG antibody was obtained from Tago Inc., Burlingame, CA. Monoclonal mouse anti-T3 (pan-T cell antigen) and anti-B1 (pan-B cell antigen) antibody conjugated with PE was obtained from Coulter Immunology, Hialeah, FL.
Immunofluorescent analysis. MNC were suspended in a staining solution (PBS plus 3% FCS and 0.1% sodium azide) at a concentration of 1 x 1 O6 cells/ml. The cell suspension was placed in micro-glass tubes (Nichiden, Kobe, Japan) in volumes of 750 pl/tube, and pelleted by centrifugation. The cells were incubated with 20 pl of 20 pg/rnl H107 antibody at 4" C for 30 min (first incubation). After being washed twice with staining solution and pelleted, the cells were incubated again with 20 p1 of 20 pg/ml FITC-conjugated goat anti-mouse IgG antibody at 4" C for 30 min (second incubation). The cells were then washed twice and resuspended in 0.5 ml of staining solution.
Controls for each sample were prepared by the same procedure except that the first incubation was performed with 20 p1 of 20 pg/ml of nonrelated mouse myeloma IgG2b protein instead of the H 107 antibody.
The Double staining analysis. Some MNC samples, which had already gone through both the first incubation with H107 antibody and the second incubation with FITC-conjugated antimouse IgG antibody according to the previously described procedure, were further incubated with PE-conjugated anti-T3 antibody or anti-B 1 antibody at 4" C for 30 min (third incubation). In control samples, MNC were not incubated with H107 antibody, but with nonrelated mouse IgG2b protein during the first incubation.
Analysis of data. Data on the percentage of FccR(+) cells are presented as the mean f 1 SD. Data on serum IgE were first transformed logarithmically and then presented as the geometric mean and a range of k 1 SD (18) . The statistical significance of the differences in the percentage of FccR(+) cells was evaluated using a t test. Although the data are not shown, the significance was also confirmed using a Wilcoxon rank-sum test. The statistical significance of the differences in IgE values was evaluated by Wilcoxon rank-sum test. In some cases, the Spearman rank correlation coefficient between the percentage of FceR(+) cells and the serum IgE level was determined. For convenience in calculation, serum IgE values lower than 1 IU/ml were all approximated at 0.5 IU/ml.
RESULTS
FccR(+) lymphocytes in children. The percentage of FccR(+) lymphocytes in children without allergic disorders showed no age-dependent variations and was the same as that of adults (Fig.  1) .
In allergic children, the percentage of FceR(+) cells was higher in children up to 2 yr of age, after which it decreased to almost the same level as nonallergic children (Fig. 1) . Allergic children, therefore, were divided into two groups; those more than and those less than 2 yr old. For statistical purposes, nonallergic children were also divided into the same two groups.
Allergic younger children (0-2 yr) had the highest percentage of FccR(+) cells, significantly higher than nonallergic younger children (0-2 yr) ( p < 0.001) or allergic older children (3-15 yr ( p < 0.00 1) ( Table 1) .
Among older children (3-15 yr), although the percentage of FccR(+) cells in allergic children was not significantly different from that of nonallergic children, 1 1 allergic children did have a Correlation ofpercentage of FceR(+) cells with serum IgE level. The mean serum IgE level in allergic children rose rapidly in early childhood (0-3 yr), and thereafter stayed constant (Fig. 2) .
Serum IgE levels in allergic children of each age group were significantly higher than those in each corresponding nonallergic group (Table 2 ). In general, there is no significant correlation between the percentage of FccR(+) cells and the serum IgE level in either allergic or nonallergic children (Table 2 ). However, in allergic younger children (0-2 yr) with serum IgE levels higher than 100 IU/ml, the percentage of FceR(+) cells did show a positive correlation to the serum IgE level (n = 8, Spearman rank = 0.88, p < 0.01).
Among allergic older children (3-15 yr), nine children with higher percentages of FceR(+) cells (>7.3%) showed higher serum IgE levels (1 174.9 IU/ml) than the other children (602.6 IU/ml, n = 37), although the difference was not significant. Two allergic older children (3-15 yr) with extremely high percentages of FccR(+) cells (>10.0%) showed much higher serum IgE levels (4365.1 IU/ml) than the other children (63 1.0 IU/ml, n = 44, p < 0.05). nonallergic, were examined by double staining with H107 antibody and either anti-T3 or anti-B 1 antibody (Table 3 ). The latter are popularly used in discriminating T and B cells, respectively, from other cells. Results of this test showed that the percentage of FccR(+) B cells was higher in allergic younger children (0-2 yr) and was, in fact, comparable to that of all FceR(+) cells. The percentage of FccR(+) T cells, however, was very low even in allergic younger children (0-2 yr). It was also very low in allergic older children (3-15 yr) (0.4 + 0.2%, n = 4).
DISCUSSION
This study shows the percentage of FccR(+) cells in nonallergic children to be constant in all age groups and equal to that of nonallergic adults ( Fig. 1 ; Table 1 ). Delespesse et al. ( 19) reported that the percentage of FccR(+) cells in cord blood was the same as that of normal adults. Both studies indicate that the percentage of FceR(+) cells in normal individuals is quite stable.
Both the percentage of FccR(+) cells and serum IgE levels in allergic younger children (0-2 yr) were significantly higher than those in nonallergic younger children (0-2 yr). A positive correlation between the percentages of FccR(+) cells and serum IgE levels was observed in patients with IgE levels higher than 100 IU/ml. Among allergic older children (3-1 5 yr), two patients with very high percentage of FceR(+) cells (>10.0%) showed extremely high serum IgE levels (>4000 IU/ml). Taking into consideration that FccR(+) cells have been shown to enhance IgE production in in vitro experiments (7) (8) (9) 20) , these results may suggest that this enhancing activity also occurs in vivo. These findings may be of value in studying the mechanism of the development of allergic disorders especially in early childhood.
FccR expression of lymphocytes is also enhanced by IgE at concentrations of about 10 pg/ml (5, 13, 14) . In previous reports, the increase of FceR(+) cells in human peripheral blood lympho- t Presented as geometric mean and 1 SD range.
$ Significantly higher than nonallergic younger children (0-2 yr) ( p < 0.01) and all nonallergic children (0-15 yr) ( p < 0.01).
4 Significantly higher than nonallergic older children (3-15 yr) ( p < 0.01) and nonallergic adults ( p < 0.01).
11 Significantly higher than nonallergic adults ( p < 0.05).
Spearman rank correlation coefficient between the percentages of FctR(+) cells and serum IgE levels. Serum IgE levels rapidly increase with age up to 3 yr, after which there is no apparent increase (Fig. 2) . The prevalent rate of antigen-specific IgE antibody against common allergens such as eggs and mites in allergic children, as determined by RAST score, also rose promptly up to 2 yr of age. Thereafter, the levels either continued to rise slowly to a maximum or, in the case of food allergens, began to decline (Ito S, Mikawa H, unpublished data). ~h & e findings suggest that the sensitization to allergens is almost comulete bv 2 or 3 vr of age. Inasmuch as an increase in the percentage o f .~c e~( + j cells b a s observed only in allergic younger children (0-2 yr) in whom intensive sensitization might be occurring, it may be a reaction related to this sensitization. Activation of T cells by allergens during the sensitizing process may cause the increase in FctR(+) cells because FctR was induced on lymphocytes by soluble factors secreted by activated T cells (10) (11) (12) . Additional investigation is required in order to confirm this assumption.
In our study, the percentage of FctR(+) T cells was too low to draw any conclusions on their behavior. However, it seems that the percentage of FccR(+) T cells did not increase even in allergic younger children (0-2 yr) despite a significant increase in the percentage of FccR(+) B cells. In animals, the function of FctR(+) B cells is presently unclear. In humans, however, FccR(+) B cells, as well as FccR(+) T cells, have been shown to have an up-regulating effect on IgE production by secreting an IgE-potentiating factor (8, 9) . If FccR(+) lymphocytes indeed enhance IgE synthesis, such an effect in allergic younger children may be due specifically to FccR(+) B cells.
